Roivant Sciences Ltd. Warrant
ROIVW
ROIVW was delisted on the 1st of September, 2023.
0 hedge funds and large institutions have $0 invested in Roivant Sciences Ltd. Warrant in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 26 closing their positions.
100% less funds holding
Funds holding: 26 → 0 (-26)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $37.6M → $0 (-$37.6M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 26
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
-$9.98M |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$5.06M |
| 3 |
D.E. Shaw & Co
New York
|
-$3.34M |
| 4 |
FBCM
Fort Baker Capital Management
Larkspur,
California
|
-$2.78M |
| 5 |
TSC
Two Seas Capital
Rye,
New York
|
-$2.73M |
ROIVW Hedge Fund Activity: Q3 2023 in Review
0 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences Ltd. Warrant (ROIVW) for Q3 2023, worth a combined $0 — down 100% from $37.6M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of ROIVW and 0 opened new positions — a net loss of 26 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was LMR Partners, exiting entirely with an estimated $9.98M sold.
- 0 institutional investors held Roivant Sciences Ltd. Warrant (ROIVW) as of Q3 2023, down from 26 in Q2 2023.
- Funds reported $0 of Roivant Sciences Ltd. Warrant stock for Q3 2023, down 100% quarter-over-quarter.
- 0 funds opened new Roivant Sciences Ltd. Warrant positions in Q3 2023 and 26 closed out, a net change of -26 holders.
- The largest Roivant Sciences Ltd. Warrant seller in Q3 2023 was LMR Partners, an estimated $9.98M sold.
Based on aggregated 13F filings for Q3 2023.